L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells.
Shigeo OhbaYuichi HirosePublished in: Journal of neuro-oncology (2020)
The results suggest that the combination of L-asparaginase and DON could be a new therapeutic option for patients with glioblastoma.